Amyloidogenicity and neurotoxicity of peptides corresponding to the helical regions of PrPC

An α‐helical to β‐sheet conformational change in the prion protein, PrPC, is believed to be causative in transmissible spongiform encephalopathies. Recent nuclear magnetic resonance structures of PrPC have identified three helical regions in the normal full‐length protein. We have synthesised peptides corresponding to these helical regions (PrP144‐154, helical region one; PrP178‐193, helical region two; and PrP198‐218, helical region three). Circular dichroism results show that the peptide corresponding to helical region one is unstructured, while peptides corresponding to the second and third helical regions have a high propensity to form β‐sheet structure in a pH‐dependent manner in aqueous solutions. Peptides corresponding to the second helical region, PrP180‐193 and PrP178‐193, are the only ones that form amyloid by electron microscopy and congo red birefringence. PrP178‐193 and the amyloidogenic Alzheimer's disease Aβ25‐25 peptide were found to promote Cu (II)‐induced lipid peroxidation and cytotoxicity in primary neuronal cultures, while PrP144‐154, PrP198‐218 and the nonamyloidogenic Aβ1‐28 had no effect on Cu (II) toxicity. There was no increase in toxicity induced by PrP178‐193 in cultures treated with Fe (II) or hydrogen peroxide, indicating a preferential modulatory effect on Cu (II) toxicity by PrP178‐193. The data suggest that the PrP178‐193 peptide has both structural and bioactive properties in common with Aβ25‐35 and that the second putative helical region of PrP could be involved in modulation of Cu (II)‐mediated toxicity in neurons during prion disease. J. Neurosci. Res. 62:293–301, 2000. © 2000 Wiley‐Liss, Inc.

[1]  C. Weissmann.  Molecular biology of transmissible spongiform encephalopathies , 1996, Progress in brain research.

[2]  C. Barrow,et al.  Solution structures of beta peptide and its constituent fragments: relation to amyloid deposition. , 1991, Science.

[3]  E. Kaiser,et al.  Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides. , 1970, Analytical biochemistry.

[4]  G. Landreth,et al.  Identification of Microglial Signal Transduction Pathways Mediating a Neurotoxic Response to Amyloidogenic Fragments of β-Amyloid and Prion Proteins , 1999, The Journal of Neuroscience.

[5]  C. Masters,et al.  Cu(II) potentiation of alzheimer abeta neurotoxicity. Correlation with cell-free hydrogen peroxide production and metal reduction. , 1999, The Journal of biological chemistry.

[6]  C. Masters,et al.  Survival of Cultured Neurons from Amyloid Precursor Protein Knock-Out Mice against Alzheimer’s Amyloid-β Toxicity and Oxidative Stress , 1998, The Journal of Neuroscience.

[7]  H. Kretzschmar,et al.  Effects of Copper on Survival of Prion Protein Knockout Neurons and Glia , 1998, Journal of neurochemistry.

[8]  C. Masters,et al.  Exacerbation of Copper Toxicity in Primary Neuronal Cultures Depleted of Cellular Glutathione , 1999, Journal of neurochemistry.

[9]  Fred E. Cohen,et al.  Conformational Transformations in Peptides Containing Two Putative α-Helices of the Prion Protein , 1995 .

[10]  M. Smith,et al.  Redox metals and neurodegenerative disease. , 1999, Current opinion in chemical biology.

[11]  C. Masters,et al.  Rapid induction of Alzheimer A beta amyloid formation by zinc. , 1994, Science.

[12]  B. Caughey,et al.  Secondary structure analysis of the scrapie-associated protein PrP 27-30 in water by infrared spectroscopy. , 1991, Biochemistry.

[13]  Werner Mueller,et al.  Protection of Flupirtine on β‐Amyloid‐Induced Apoptosis in Neuronal Cells In Vitro: Prevention of Amyloid‐Induced Glutathione Depletion , 1997, Journal of neurochemistry.

[14]  H. Kretzschmar,et al.  Mouse cortical cells lacking cellular PrP survive in culture with a neurotoxic PrP fragment , 1994, Neuroreport.

[15]  G. Forloni,et al.  Neurotoxicity of a prion protein fragment , 1993, Nature.

[16]  K Wüthrich,et al.  NMR characterization of the full‐length recombinant murine prion protein, mPrP(23–231) , 1997, FEBS letters.

[17]  Stephen J. DeArmond,et al.  Prion protein amyloid and neurodegeneration , 1995 .

[18]  J Collinge,et al.  Reversible conversion of monomeric human prion protein between native and fibrilogenic conformations. , 1999, Science.

[19]  J. Ghiso,et al.  Synthetic peptides corresponding to different mutated regions of the amyloid gene in familial Creutzfeldt-Jakob disease show enhanced in vitro formation of morphologically different amyloid fibrils. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[20]  R. Riek,et al.  NMR structure of the mouse prion protein domain PrP(121–231) , 1996, Nature.

[21]  W. Surewicz,et al.  pH-dependent Stability and Conformation of the Recombinant Human Prion Protein PrP(90–231)* , 1997, The Journal of Biological Chemistry.

[22]  R. Prince,et al.  Prions are copper-binding proteins. , 1998, Trends in biochemical sciences.

[23]  K Wüthrich,et al.  Prion protein NMR structure and familial human spongiform encephalopathies. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[24]  C. Soto,et al.  The conformation of Alzheimer's beta peptide determines the rate of amyloid formation and its resistance to proteolysis. , 1996, The Biochemical journal.

[25]  M. Mattson,et al.  Evidence that 4-Hydroxynonenal Mediates Oxidative Stress-Induced Neuronal Apoptosis , 1997, The Journal of Neuroscience.

[26]  C. Masters,et al.  Amyloid plaque core protein in Alzheimer disease and Down syndrome. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[27]  F. Cohen,et al.  Predicted alpha-helical regions of the prion protein when synthesized as peptides form amyloid. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[28]  W. D. Ehmann,et al.  Copper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer's disease: possible relation to oxidative stress , 1996, Journal of the Neurological Sciences.

[29]  F. Cohen,et al.  Copper binding to the prion protein: structural implications of four identical cooperative binding sites. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[30]  S. Bondy,et al.  Promotion of transition metal-induced reactive oxygen species formation by β-amyloid , 1998, Brain Research.

[31]  H. Ushijima,et al.  Effect of Flupirtine on Bcl-2 and Glutathione Level in Neuronal Cells Treatedin Vitrowith the Prion Protein Fragment (PrP106-126) , 1997, Experimental Neurology.

[32]  C. Masters,et al.  Interaction between the zinc(II) and the heparin binding site of the Alzheimer's disease βA4 amyloid precursor protein (APP) , 1994, FEBS letters.

[33]  Mark A. Smith,et al.  In Situ Oxidative Catalysis by Neurofibrillary Tangles and Senile Plaques in Alzheimer’s Disease , 2000, Journal of neurochemistry.

[34]  Xudong Huang,et al.  The A beta peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction. , 1999, Biochemistry.

[35]  R J Fletterick,et al.  Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[36]  Xudong Huang,et al.  Dramatic Aggregation of Alzheimer Aβ by Cu(II) Is Induced by Conditions Representing Physiological Acidosis* , 1998, The Journal of Biological Chemistry.

[37]  Fran Maher,et al.  The Hydrophobic Core Sequence Modulates the Neurotoxic and Secondary Structure Properties of the Prion Peptide 106‐126 , 1999, Journal of neurochemistry.

[38]  M. Pocchiari.  Prions and related neurological diseases , 1994, Molecular Aspects of Medicine.

[39]  L. Tjernberg,et al.  The Alzheimer A beta peptide develops protease resistance in association with its polymerization into fibrils. , 1994, The Journal of biological chemistry.

[40]  C. Barrow,et al.  Solution conformations and aggregational properties of synthetic amyloid beta-peptides of Alzheimer's disease. Analysis of circular dichroism spectra. , 1992, Journal of molecular biology.

[41]  G. Forloni,et al.  Influence of mutations associated with familial prion‐related encephalopathies on biological activity of prion protein peptides , 1999, Annals of neurology.

[42]  J. Collinge,et al.  Strain-specific prion-protein conformation determined by metal ions , 1999, Nature Cell Biology.